| NCT ID | NCT04345627 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cerebral and Cardiovascular Center, Japan |
| Condition | Arrhythmia, Cardiac |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2018-07-01 |
| Primary Completion | 2032-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2018-07-01 with a primary completion date of 2032-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Japanese Lead Extraction (J-LEX) Registry is an observational nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The acute success rate at discharge and the complications associated with transvenous lead extraction will be collected. J-LEX registry will provide a reliable information on indications, methods, the success rate, complications and the prognosis at 30 days prognosis.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing transvenous lead extraction in Japan. Exclusion Criteria: * Patients who receive open-chest surgical extraction alone. * Patients who refused to consent.
Contact & Investigator
Kengo Kusano, MD, PhD
PRINCIPAL INVESTIGATOR
National Cerebral and Cardiovascular Center, Japan
Frequently Asked Questions
Who can join the NCT04345627 clinical trial?
This trial is open to participants of all sexes, studying Arrhythmia, Cardiac. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04345627 currently recruiting?
Yes, NCT04345627 is actively recruiting participants. Contact the research team at kusanokengo@ncvc.go.jp for enrollment information.
Where is the NCT04345627 trial being conducted?
This trial is being conducted at Suita, Japan.
Who is sponsoring the NCT04345627 clinical trial?
NCT04345627 is sponsored by National Cerebral and Cardiovascular Center, Japan. The principal investigator is Kengo Kusano, MD, PhD at National Cerebral and Cardiovascular Center, Japan. The trial plans to enroll 5,000 participants.